X-Linked Hypophosphatemia clinical trials at UCLA

1 in progress, 0 open to eligible people

X-linked Hypophosphatemia Disease Monitoring Program
Sorry, in progress, not accepting new patients
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.
Los Angeles, California and other locations

Last updated: March 7, 2024